Microplastics in ventilator tubing and lung risk in premature babies
Part of Genetic & congenital, Lungs & breathing, Women’s health & pregnancy clinical trials.
This study looks at whether tiny plastic particles (microplastics) in the breathing tube used for premature babies on a ventilator might be linked to a lung condition called bronchopulmonary dysplasia (BPD). It aims to help understand if these particles could increase the risk of lung problems in these vulnerable infants.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be born prematurely and need a breathing tube (ventilator) to help them breathe.
- Your baby must not have a genetic metabolic disease or a congenital heart defect that could affect the study results.
- You (the parent or guardian) must agree to let your baby participate in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the natural bacteria and germs in a premature baby's airways to see if they can help predict whether the baby will develop a lung problem called bronchopulmonary dysplasia (BPD). The goal is to find early clues that help doctors take better care of these babies.
This study looks at babies born very early who have severe lung disease (grade 3 BPD) and still need a breathing machine. Researchers will use tests to understand their lung problems better, which may help guide their care.
This Phase 1 trial tests whether giving stem cells into a breathing tube is safe and may help prevent bronchopulmonary dysplasia (BPD), a serious lung condition in very premature infants. It focuses on babies soon after birth who already need breathing support and are at risk.
This study looks at very early signs of a lung problem called bronchopulmonary dysplasia in babies born before 26 weeks of pregnancy. The goal is to find better ways to predict and maybe prevent this condition.
This study tests a new way of setting the ventilator for preterm babies born before 34 weeks who are still on a breathing machine. It aims to improve lung healing and heart function by finding the best pressure settings. The results could help your baby breathe more comfortably.
This study tests whether a special cell therapy (MSC-EVs) given to extremely premature babies can help prevent a serious lung disease called bronchopulmonary dysplasia (BPD). The treatment is given while the baby is still on a breathing machine.
Hear when a new Bronchopulmonary Dysplasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.